319 related articles for article (PubMed ID: 8018536)
21. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors.
Curnow A; Pye A
J Environ Pathol Toxicol Oncol; 2007; 26(2):89-103. PubMed ID: 17725535
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX.
Gilaberte Y; Pereboom D; Carapeto FJ; Alda JO
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):43-9. PubMed ID: 9361128
[TBL] [Abstract][Full Text] [Related]
23. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid.
Betz CS; Lai JP; Xiang W; Janda P; Heinrich P; Stepp H; Baumgartner R; Leunig A
Photochem Photobiol Sci; 2002 May; 1(5):315-9. PubMed ID: 12653468
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
Chang SC; MacRobert AJ; Porter JB; Bown SG
J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
26. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines.
Sharma S; Jajoo A; Dube A
J Photochem Photobiol B; 2007 Sep; 88(2-3):156-62. PubMed ID: 17761434
[TBL] [Abstract][Full Text] [Related]
27. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
29. 5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line.
Vena FC; Turchiello RF; Laville I; Pigaglio S; Blais J; Tedesco AC
Lasers Med Sci; 2004; 19(2):119-26. PubMed ID: 15340863
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
31. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.
Ortel B; Chen N; Brissette J; Dotto GP; Maytin E; Hasan T
Br J Cancer; 1998 Jun; 77(11):1744-51. PubMed ID: 9667642
[TBL] [Abstract][Full Text] [Related]
32. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
Pye A; Curnow A
Photochem Photobiol; 2007; 83(3):766-73. PubMed ID: 17576385
[TBL] [Abstract][Full Text] [Related]
33. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
34. Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer.
Seidl J; Rauch J; Krieg RC; Appel S; Baumgartner R; Knuechel R
Int J Cancer; 2001 Jun; 92(5):671-7. PubMed ID: 11340570
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
36. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
37. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
Novak B; Heesen L; Schary N; Lübbert H
Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
[TBL] [Abstract][Full Text] [Related]
38. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?
Gibson SL; Cupriks DJ; Havens JJ; Nguyen ML; Hilf R
Br J Cancer; 1998; 77(2):235-42. PubMed ID: 9460994
[TBL] [Abstract][Full Text] [Related]
39. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
40. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
